These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 18306350)

  • 1. 9p21 Deletion in the diagnosis of malignant mesothelioma in serous effusions additional to immunocytochemistry, DNA-ICM, and AgNOR analysis.
    Onofre FB; Onofre AS; Pomjanski N; Buckstegge B; Grote HJ; Böcking A
    Cancer; 2008 Jun; 114(3):204-15. PubMed ID: 18306350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphology of 9p21 homozygous deletion-positive pleural mesothelioma cells analyzed using fluorescence in situ hybridization and virtual microscope system in effusion cytology.
    Matsumoto S; Nabeshima K; Kamei T; Hiroshima K; Kawahara K; Hata S; Marukawa K; Matsuno Y; Taguchi K; Tsujimura T
    Cancer Cytopathol; 2013 Aug; 121(8):415-22. PubMed ID: 23450849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Static DNA cytometry as a diagnostic aid in effusion cytology: I. DNA aneuploidy for identification and differentiation of primary and secondary tumors of the serous membranes.
    Motherby H; Marcy T; Hecker M; Ross B; Nadjari B; Auer H; Müller KM; Häussinger D; Strauer BE; Böcking A
    Anal Quant Cytol Histol; 1998 Jun; 20(3):153-61. PubMed ID: 9642441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptation of a commercial fluorescent in situ hybridization test to the diagnosis of malignant cells in effusions.
    Flores-Staino C; Darai-Ramqvist E; Dobra K; Hjerpe A
    Lung Cancer; 2010 Apr; 68(1):39-43. PubMed ID: 19523712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions.
    Illei PB; Ladanyi M; Rusch VW; Zakowski MF
    Cancer; 2003 Feb; 99(1):51-6. PubMed ID: 12589646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 9p21 deletion in the diagnosis of malignant mesothelioma, using fluorescence in situ hybridization analysis.
    Takeda M; Kasai T; Enomoto Y; Takano M; Morita K; Kadota E; Nonomura A
    Pathol Int; 2010 May; 60(5):395-9. PubMed ID: 20518890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early diagnosis of mesothelioma in serous effusions using AgNOR analysis.
    Pomjanski N; Motherby H; Buckstegge B; Knops K; Rohn BL; Böcking A
    Anal Quant Cytol Histol; 2001 Apr; 23(2):151-60. PubMed ID: 11332082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic analysis of effusions from malignant mesothelioma. A diagnostic adjunct to cytology.
    Granados R; Cibas ES; Fletcher JA
    Acta Cytol; 1994; 38(5):711-7. PubMed ID: 8091903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Image cytometry: an aid for cytological diagnosis of pleural effusions.
    Osterheld MC; Liette C; Anca M
    Diagn Cytopathol; 2005 Mar; 32(3):173-6. PubMed ID: 15690335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of numerical aberrations of chromosomes 7 and 9 in cytologic specimens of pleural malignant mesothelioma.
    Shin HJ; Shin DM; Tarco E; Sneige N
    Cancer; 2003 Aug; 99(4):233-9. PubMed ID: 12925985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early cytological diagnosis of diffuse malignant mesothelioma of the peritoneum: a case report.
    Pomjanski N; Grote HJ; Sander O; Heikaus S; Müller KM; Böcking A
    Diagn Cytopathol; 2008 Feb; 36(2):120-3. PubMed ID: 18181185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scoring system for differential diagnosis of malignant mesothelioma and reactive mesothelial cells on cytology specimens.
    Kimura N; Dota K; Araya Y; Ishidate T; Ishizaka M
    Diagn Cytopathol; 2009 Dec; 37(12):885-90. PubMed ID: 19572412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Static DNA cytometry as a diagnostic aid in effusion cytology: II. DNA aneuploidy for identification of neoplastic cells in equivocal effusions.
    Motherby H; Nadjari B; Remmerbach T; Marcy T; Pomjanskaja N; Müller W; Knops K; Häussinger D; Strauer BE; Böcking A
    Anal Quant Cytol Histol; 1998 Jun; 20(3):162-8. PubMed ID: 9642442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
    Friedman MT; Gentile P; Tarectecan A; Fuchs A
    Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry.
    Su XY; Li GD; Liu WP; Xie B; Jiang YH
    Diagn Cytopathol; 2011 Dec; 39(12):900-8. PubMed ID: 20836004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic significance of carcinoembryonic antigen in the differential diagnosis of malignant mesothelioma.
    Mezger J; Lamerz R; Permanetter W
    J Thorac Cardiovasc Surg; 1990 Dec; 100(6):860-6. PubMed ID: 2147220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
    Ylagan LR; Zhai J
    Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of mesothelioma from adenocarcinoma in serous effusions: the role of hyaluronic acid and CD44 localization.
    Afify AM; Stern R; Michael CW
    Diagn Cytopathol; 2005 Mar; 32(3):145-50. PubMed ID: 15690337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of argyrophilic nucleolar organiser regions in pleural and peritoneal effusions.
    Khan SA; Chaudhry NA; Khalid AW; Akhtar GN; Ibne-Rasa SN
    J Coll Physicians Surg Pak; 2006 Jun; 16(6):412-5. PubMed ID: 16787619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of cytology, fluorescence in situ hybridization for aneuploidy, and reverse-transcriptase polymerase chain reaction for human mammaglobin/mammaglobin B expression improves diagnosis of malignant effusions.
    Fiegl M; Haun M; Massoner A; Krugmann J; Müller-Holzner E; Hack R; Hilbe W; Marth C; Duba HC; Gastl G; Grünewald K
    J Clin Oncol; 2004 Feb; 22(3):474-83. PubMed ID: 14752070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.